Corporate News
BIOFISICA APPOINTS RICK HILLSTEAD AS CHAIRMAN OF THE BOARD AND CEO
ATLANTA - Aug. 20, 2009 - Biofisica Inc. is pleased to announce that as of June 2009 Rick Hillstead Ph.D., FAHA, has joined the Company as Chairman of the Board and Chief Executive Officer. Hillstead is currently a Partner with Georgia Venture Partners and has been actively involved in the design and development of medical devices since 1983. Most recently, he was a founding member of The Innovation Factory (TIF) and a principal partner in Accuitive Medical Ventures I and II . At TIF he served as Chief Science Officer and was primarily responsible for technical due diligence and deal structure in areas of Interventional Cardiology and Orthopaedics.
BIOFISICA OBTAINS $2.3 MILLION IN FINANCING FROM INVESTORS
Biofisica Inc, an Atlanta based company specializing in wound care therapy, today announced that it has obtained a comittment of $2.3 million in financing from investors. The funding will support Biofisica's continued marketing efforts in the UK and ongoing planning initiatives in the US. (Read More...)
BIOFISICA SIGNS UK DISTRIBUTION AGREEMENT
Biofisica the leading manufacturer of bio-current threapy wound healing technology has appointed Sumed International (UK) Ltd (Sumed) as the exclusive distributor of Biofisica's POSiFECT® bio-electric stimulation therapy product range to the United Kingdom and Ireland markets. (Read More...)
BIOFISICA AND WOUNDS UK LAUNCHES TRAINING PROGRAMME FOR WOUND CARE CLINICIANS
Biofisica and its communication partner Wounds UK are launching a series of one day workshops across England outlining the role of bio-electric currents in wound healing. This new treatment modality is now commercially available as POSiFECT®. (Read More...)
ATLANTA-BASED BIOFISICA™ SECURES $2 IN FINANCING FROM LEADER VENTURES
ATLANTA—Aug.8, 2007 – Biofisica Inc., an Atlanta, Georgia-based innovator in wound care therapy, today announced the company has obtained $2 million in venture debt financing from Leader Ventures. Biofisica plans to use the funds for working capital and operational expenses related to its pioneering wound care product, POSiFECT® Bio-Electric Stimulation Therapy. The product was launched in early 2007 and is now being marketed and sold in the United Kingdom. (Read More...)
ATLANTA-BASED BIOFISICA™ NAMES GLEN BRADLEY TO ITS BOARD
ATLANTA—Nov. 30, 2006 – Biofisica Inc., an Atlanta, Georgia-based high tech wound care company, announced today that Glen Bradley, Ph.D., has joined its board of directors. Bradley, highly respected in the medical device and biotech industries, served from 1990 until his retirement in 2003 as CEO of CIBA Vision, a global leader in the research, development and manufacturing of contact lenses and lens care products. CIBA Vision is the eye care unit of Novartis AG, one of the largest healthcare companies in the world. (Read More...)
ATLANTA-BASED BIOFISICA™ NAMES BLOUNT SWAIN TO ITS BOARD
ATLANTA - Jun. 2006 - Medical device startup Biofisica Inc. has named J. Blount Swain to its board of directors. A financial management executive with a diverse background, Swain has 25 years of experience in the software, medical device, retail and public-accounting industries. Currently he serves as an entrepreneur-in-residence to a private investment group, managing its portfolio of companies and conducting due diligence for additional equity infusions. (Read More...)
